Inventor · disambiguated record
Nathalie Bonnefoy
Also filed as: BONNEFOY NATHALIE
4 granted patents·7 pending applications·7 citations·filing 2004–2021
67Inventor score
Files withOREGA BIOTECH7INST NAT SANTE RECH MED2DI RAGO JEAN-PAUL1INST MEDICAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
11 records- 0176US10351623B2Antagonists of IL-17 isoforms and their usesOREGA BIOTECH·Filed 2017·Granted Jul 16, 2019·3 cites·11 claims
- 0265US9676847B2IL-17 antagonist antibodiesOREGA BIOTECH·Filed 2013·Granted Jun 13, 2017·1 cites·33 claims
- 0364US9834601B2Antagonists of IL-17 isoforms and their usesOREGA BIOTECH·Filed 2013·Granted Dec 5, 2017·1 cites·6 claims
- 0452US2017233468A1Il-17 antagonist antibodiesOREGA BIOTECH·Filed 2017·Application pending·0 cites
- 0549US8143061B2Industrial method for producing RNA and system for carrying out said methodDI RAGO JEAN-PAUL·Filed 2004·Granted Mar 27, 2012·2 cites·18 claims
- 0649US2023086718A1Method for predicting the survival time of a patient suffering from a cancerINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0747US2023045494A1Combination therapies based on ctla4 and il-17b inhibitorsOREGA BIOTECH·Filed 2021·Application pending·0 cites
- 0845US2022281967A1Novel il-17b antibodiesOREGA BIOTECH·Filed 2020·Application pending·0 cites
- 0943US2022064332A1Methods and compositions for treating cancers by immuno-modulation using antibodies against cathespin-dINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1042US2022175815A1Combination therapies based on pd1 and il-17b inhibitorsOREGA BIOTECH·Filed 2020·Application pending·0 cites
- 1141US2014023650A1Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 AntagonistsINST MEDICAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathalie Bonnefoy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →